Pancreatic Neoplasms mortality rate and epidemiological profile in Brazil between 2018 and 2022

Authors

  • Cleidiana Alves de Brito 1Médica pela Faculdade Unifranz Tomayo
  • Andreza Ossani 2Nutricionista pela Universidade de Passo Fundo
  • Mila Maia Martins Acadêmica de Medicina pela FACID Idomed
  • Weslley Barbosa Maia Acadêmico de Medicina pela CEUMA
  • Kauann Lopes Soares Acadêmico de Medicina pela Universidad Maria Auxiliadora
  • Maria Eduarda Barbosa de Souza Médica pela Universidade de Pernambuco
  • Gabriel Rocha Pinon Teixeira de Araújo Acadêmico de Medicina pela Universidade Católica de Pernambuco.
  • Walquiria da Silva Pedra Parreira Acadêmica de Medicina pelo Centro Universitário de Valença.
  • Radijames de Jesus Silva Ribeiro Acadêmica de Enfermagem pela Universidade CEUMA
  • Rafael Lucas Santos Oliveira Gomes Acadêmico de Medicina pela Universidade Federal do Rio Grande do Norte
  • Rodrigo da Silva Bezerra Fisioterapeuta pelo Centro Universitário Maurício de Nassau
  • Rodrigo Daniel Zanoni Mestre em Saúde Coletiva pela Faculdade São Leopoldo Mandic Campinas.

DOI:

https://doi.org/10.36557/2674-8169.2024v6n1p1186-1195

Keywords:

Epidemiology, Pancreatic Neoplasms, Mortality

Abstract

This article aims to analyze the epidemiology of hospitalizations and the mortality rate due to malignant neoplasia of the pancreas, in Brazil, in the last five years, based on secondary data available in the database of the Department of Informatics of the Unified Health System (DATASUS ). This is a cross-sectional descriptive study, with a documentary approach, using secondary data collected in DATASUS. During the period analyzed, 68,693 hospitalizations for malignant neoplasia of the pancreas were recorded in Brazil. It is concluded that population density, socioeconomic conditions and access to advanced medical centers influenced this distribution. Remarkable advances have been made, including the identification of risk factors such as smoking and obesity, and the association with glucose problems and diabetes as early indicators.

Downloads

Download data is not yet available.

References

DATASUS – Ministério da Saúde. Disponível em: <https://datasus.saude.gov.br/>. Acesso em: 11 jan. 2024.

BRUNNER, M. et al. Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions. International Journal of Molecular Sciences, v. 20, n. 18, 13 set. 2019.

HALBROOK, C. J. et al. Pancreatic cancer: Advances and challenges. Cell, v. 186, n. 8, p. 1729–1754, 13 abr. 2023.

HU, J.-X. et al. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World Journal of Gastroenterology, v. 27, n. 27, p. 4298–4321, 21 jul. 2021.

MCGUIGAN, A. et al. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. World Journal of Gastroenterology, v. 24, n. 43, p. 4846–4861, 21 nov. 2018.

MEDRONHO, R. Epidemiologia. 2ª edição. São Paulo, 2009.

MIZRAHI, J. D. et al. Pancreatic cancer. The Lancet, v. 395, n. 10242, p. 2008–2020, 27 jun. 2020.

PARK, W.; CHAWLA, A.; O’REILLY, E. M. Pancreatic Cancer. JAMA, v. 326, n. 9, p. 851–862, 7 set. 2021.

PEREIRA, S. P. et al. Early detection of pancreatic cancer. The Lancet Gastroenterology & Hepatology, v. 5, n. 7, p. 698–710, jul. 2020.

STOFFEL, E. M.; BRAND, R. E.; GOGGINS, M. Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk assessment, Early Detection, and Prevention. Gastroenterology, fev. 2023.

TEMPERO, M. A. et al. Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network: JNCCN, v. 19, n. 4, p. 439–457, 1 abr. 2021.

TIMMER, F. E. F. et al. Pancreatic Cancer and Immunotherapy: A Clinical Overview. Cancers, v. 13, n. 16, p. 4138, 1 jan. 2021.

TONINI, V.; ZANNI, M. Pancreatic cancer in 2021: What you need to know to win. World Journal of Gastroenterology, v. 27, n. 35, p. 5851–5889, 21 set. 2021.

ZHAO, Z.; LIU, W. Pancreatic Cancer: A Review of Risk Factors, Diagnosis, and Treatment. Technology in Cancer Research & Treatment, v. 19, p. 153303382096211, 1 jan. 2020.

Downloads

Published

2024-01-16

How to Cite

Alves de Brito, C., Ossani, A., Maia Martins , M., Barbosa Maia, W., Lopes Soares , K., Barbosa de Souza, M. E., Rocha Pinon Teixeira de Araújo, G., da Silva Pedra Parreira , W., de Jesus Silva Ribeiro, R., Lucas Santos Oliveira Gomes, R., da Silva Bezerra, R., & Daniel Zanoni, R. (2024). Pancreatic Neoplasms mortality rate and epidemiological profile in Brazil between 2018 and 2022. Brazilian Journal of Implantology and Health Sciences, 6(1), 1186–1195. https://doi.org/10.36557/2674-8169.2024v6n1p1186-1195

Issue

Vol. 6 No. 1 (2024): BJIHS QUALIS B3

Section

Original article

License

Copyright (c) 2024 Cleidiana Alves de Brito, Andreza Ossani, Mila Maia Martins , Weslley Barbosa Maia, Kauann Lopes Soares , Maria Eduarda Barbosa de Souza, Gabriel Rocha Pinon Teixeira de Araújo, Walquiria da Silva Pedra Parreira , Radijames de Jesus Silva Ribeiro, Rafael Lucas Santos Oliveira Gomes, Rodrigo da Silva Bezerra, Rodrigo Daniel Zanoni

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors are copyright holders under a CCBY 4.0 license.